Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 69.08 M119.56 M129.3 M97.61 M95.45 M 441.93 M Research & development ————— — Operating income 65.33 M76.43 M40.09 M50.11 M59.18 M 225.82 M Non-Operating Income, Total 4.24 M5.76 M7.01 M7.25 M10.25 M 30.27 M Interest expense, net of interest capitalized 14.74 M14.11 M14.07 M15.32 M13.69 M 57.19 M Non-Operating Income, excl. Interest Expenses -15.19 M-14.55 M-14.51 M-17.23 M-14.17 M -60.47 M Unusual income/expense 4.69 M6.2 M7.46 M9.16 M10.73 M 33.55 M Pretax income 55.66 M69.05 M34 M45.8 M56.51 M 205.36 M Equity in earnings ————— — Taxes 12.91 M21.96 M15.15 M11.4 M16.98 M 65.5 M Non-controlling/minority interest 14.75 M27.11 M15.22 M5.56 M13.83 M 61.72 M After tax other income/expense -1.3 M-3.47 M1.93 M-1.67 M904 K -2.31 M Net income before discontinued operations 28 M19.97 M3.63 M28.84 M25.7 M 78.14 M Discontinued operations ————— — Net income 28 M19.97 M3.63 M28.84 M25.7 M 78.14 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 28 M19.97 M3.63 M28.84 M25.7 M 78.14 M Basic earnings per share (Basic EPS) 0.530.380.070.550.49 1.49 Diluted earnings per share (Diluted EPS) 0.530.380.070.530.48 1.46 Average basic shares outstanding 52.54 M52.72 M52.74 M52.69 M52.74 M — Diluted shares outstanding 53.01 M53.19 M53.66 M53.41 M53.75 M — EBITDA 65.42 M79.4 M40.99 M50.06 M59.34 M 229.78 M EBIT 52.65 M66.55 M28.74 M36.25 M47.87 M 179.41 M Cost of revenue 1.11 B1.18 B1.25 B1.36 B1.23 B 5.02 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 12.57 M12.84 M12.25 M13.81 M11.47 M 50.37 M